Advertisement

T-ALL Minimal Residual Disease Using a Simplified Gating Strategy and Its Clinico-hematologic Correlation: A Single Center Experience from North India

  • Neha SinghEmail author
  • Narendra Agrawal
  • Ridhi Sood
  • Gayatri Vishwakarma
  • Dushyant Kumar
  • Surender Dhanda
  • Narender Tejwani
  • Rayaz Ahmed
  • Dinesh Bhurani
  • Anurag Mehta
Short Communication

Abstract

The presence of minimal residual disease (MRD) is one of the strong predictors of disease outcome in various hematological malignancies including B-ALL and T-ALL, independent of pre-therapeutic risk factors. There is scant Indian data on MRD by flowcytometry in T-ALL including gating strategies, clinical correlation etc. The primary aim of this retrospective observational study was to define the clinico-hematologic characteristics and prognostic significance of patients with ETP/near-ETP versus non-ETP immunophenotype, especially in terms of minimal residual disease at different time points as well as event-free survival (1 year). Baseline hematologic characteristics along with post-induction (Day-35) and post-consolidation (Day-78) MRD in bone marrow samples from newly diagnosed T-ALL patients were studied. 14.3% patients had ETP-ALL immunophenotype, 11.4% were near-ETP ALL patients and the remaining 74.5% were of non-ETP subtype. The ETP/near ETP patients was significantly associated with higher risk of MRD positivity ( > 0.01%) at the end of induction in comparison to the non-ETP patients (p = 0.033). Also, these patients showed a trend towards proclivity to anemia (p = 0.06) and higher rates of induction failure (p = 0.07) However, no difference was observed between the two subgroups in terms of age, high TLC, thrombocytopenia, adverse cytogenetics, steroid responsiveness on Day + 8 of induction, MRD-positivity > 0.01% at the end of consolidation and EFS-1 year. Through this preliminary study, it can be stated clearly that ETP status is associated with MRD > 0.01% post-induction but has no significant impact on long-term survival of these patients.

Keywords

Minimal residual disease Acute lymphoblastic leukemia Immunophenotyping 

Notes

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Brüggemann M, Kotrova M (2017) Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation. Blood Adv 1(25):2456–2466CrossRefGoogle Scholar
  2. 2.
    Roshal M, Fromm JR, Winter S, Dunsmore K, Wood BL (2010) Immaturity associated antigens are lost during induction for T-cell lymphoblastic leukemia: implications for minimal residual disease detection. Cytometry B Clin Cytom 78:139–146CrossRefGoogle Scholar
  3. 3.
    Patrick K, Wade R, Goulden N, Mitchell C, Moorman AV, Rowntree C et al (2014) Outcome for children and young people with early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol 166:421–424CrossRefGoogle Scholar
  4. 4.
    Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al (2009) Early T-cell precursor leukemia: a subtype of very high-risk acute lymphoblastic leukemia identified in two independant cohorts. Lancet Oncol 10:147–156Google Scholar
  5. 5.
    Wood BL, Winter SS, Dunsmore KP, Devidas M, Chen S, Asselin B et al (2014) T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in Children's Oncology Group (COG) Study AALL0434. Blood 124(21):1CrossRefGoogle Scholar
  6. 6.
    Tembhare P, Chatterjee G, Sanyal I, Devre P, Ghogale S, Patkar N et al (2017) Post-induction minimal residual disease response determined by multicolor flow cytometry is a powerful indicator of event-free-survival in the childhood T-cell acute lymphoblastic leukemia. EHA Learning Center 180613. Eposter E837Google Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2019

Authors and Affiliations

  • Neha Singh
    • 1
    Email author
  • Narendra Agrawal
    • 2
  • Ridhi Sood
    • 1
  • Gayatri Vishwakarma
    • 3
  • Dushyant Kumar
    • 4
  • Surender Dhanda
    • 4
  • Narender Tejwani
    • 1
  • Rayaz Ahmed
    • 2
  • Dinesh Bhurani
    • 2
  • Anurag Mehta
    • 1
  1. 1.Department of Pathology and Lab ServicesRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia
  2. 2.Department of Hemato-OncologyRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia
  3. 3.Department of ResearchRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia
  4. 4.Department of Molecular DiagnosticsRajiv Gandhi Cancer Institute and Research CenterNew DelhiIndia

Personalised recommendations